胸膜上皮瘤的自身免疫:一个尚未明确的病理范式,与几个未满足的临床需求相关
Matteo Perrino1, Emanuele Voulaz2,3, Simone Balin4
1Department of Medical Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy.
Frontiers in immunology
|April 17, 2024
概括
胸膜上皮瘤 (TETs) 可以引发自身免疫性疾病,特别是胸膜瘤. 了解相关的免疫细胞和机制对于开发用于这些罕见癌症的新疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 甲状腺上皮瘤 (TET) 是一种罕见的中癌,影响甲状腺,甲状腺是T细胞平衡的关键器官.
- 胸腺瘤,与胸腺癌不同,经常与自身免疫性疾病 (ADs) 相关,最常见的是 Myasthenia Gravis.
研究的目的:
- 审查TET基因型的组织学特征.
- 探索免疫细胞在瘤微环境中的作用及其对胸膜耐受性的影响.
- 讨论TETs自身免疫的基础免疫机制.
主要方法:
- 对TETs组织学特征的文献综述.
- 对TET微环境中的免疫细胞透的分析.
- 讨论细胞和分子免疫机制.
主要成果:
- 胸腺瘤与残留性胸腺形成有关,特别是在特定亚型 (AB,B) 中.
- 免疫细胞的透和改变的胸膜耐受性有助于TET患者的AD发展.
- 自身免疫性使治疗选择复杂化,不包括检查点抑制剂等免疫疗法.
结论:
- 试管婴儿和自身免疫之间的相互作用是复杂的,并未完全理解.
- 了解这些机制对于改善治疗策略和患者预后至关重要.
- 需要进一步的研究来应对TET管理中伴随性疾病所带来的挑战.
相关概念视频
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cell-mediated Immune Responses
68.2K
Overview
68.2K
T Cell Activation and Clonal Selection
716
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
716


